Concepedia

Patients with Epstein–Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease

Takashi Sekine, Mutsuko Konno, Satoshi Sasaki, Suzuko Moritani, Takuma Miura, Wai-shan Wong, Hisanori Nishio, Toshihiro Nishiguchi, Miyako Yoshinari Ohuchi, Shigeru Tsuchiya,

Kidney International · 2010 · 111 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis

Joshua M. Kaplan, Sung Hyun Kim, Kathryn N. North et al. · Nature Genetics · 2000 · 1.2K citations

, , +12

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

Jeffrey B. Kopp, Michael W. Smith, George W. Nelson et al. · Nature Genetics · 2008 · 708 citations

, , +13

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

W.H. Linda Kao, Michael J. Klag, Lucy A. Meoni et al. · Nature Genetics · 2008 · 648 citations · Full text

, , +12

Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes

The May-Hegglin Fechtner Syndrome Consortium · Nature Genetics · 2000 · 448 citations

, , +8

Nonmuscle myosin II moves in new directions

Mary Anne Conti, Robert Adelstein · Journal of Cell Science · 2007 · 352 citations

, , +14